Over 80 p.c of 200 COVID-19 sufferers in a hospital in Spain have vitamin D deficiency, in line with a brand new examine printed within the Endocrine Society’s Journal of Medical Endocrinology & Metabolism.
Vitamin D is a hormone the kidneys produce that controls blood calcium focus and impacts the immune system. Vitamin D deficiency has been linked to a range of well being issues, though analysis continues to be underway into why the hormone impacts different techniques of the physique. Many research level to the helpful impact of vitamin D on the immune system, particularly relating to safety towards infections.
“One strategy is to determine and deal with vitamin D deficiency, particularly in high-risk people such because the aged, sufferers with comorbidities, and nursing dwelling residents, who’re the principle goal inhabitants for the COVID-19,” stated examine co-author José L. Hernández, Ph.D., of the College of Cantabria in Santander, Spain. “Vitamin D remedy needs to be really helpful in COVID-19 sufferers with low ranges of vitamin D circulating within the blood since this strategy might need helpful results in each the musculoskeletal and the immune system.”
The researchers discovered 80 p.c of 216 COVID-19 sufferers on the Hospital Universitario Marqués de Valdecilla had vitamin D deficiency, and males had decrease vitamin D ranges than ladies. COVID-19 sufferers with decrease vitamin D ranges additionally had raised serum ranges of inflammatory markers equivalent to ferritin and D-dimer.
Reference “Vitamin D Standing in Hospitalized Patients With SARS-Cov-2 An infection” by José L Hernández, Daniel Nan, Marta Fernandez-Ayala, Mayte García-Unzueta, Miguel A Hernández-Hernández, Marcos López-Hoyos, Pedro Muñoz Cacho, José M Olmos, Manuel Gutiérrez-Cuadra, Juan J Ruiz-Cubillán, Javier Crespo and Víctor M Martínez-Taboada, 27 October 2020, Journal of Medical Endocrinology & Metabolism.
Different authors of the examine embody: Daniel Nan, José M. Olmos, Javier Crespo, and Víctor M. Martínez-Taboada of the College of Cantabria; Marta Fernandez-Ayala, Mayte García-Unzueta, Miguel A. Hernández-Hernández, Marcos López-Hoyos, Manuel Gutiérrez-Cuadra, and Juan J. Ruiz-Cubillán of the Hospital Marqués de Valdecilla-IDIVAL in Santander, Spain; Pedro Muñoz Cacho of the Servicio Cántabro de Salud in Santander, Spain;
The manuscript acquired funding from Instituto de Salud Carlos III.